Published in Genes Dev on June 01, 1992
A large-scale, gene-driven mutagenesis approach for the functional analysis of the mouse genome. Proc Natl Acad Sci U S A (2003) 3.05
Rex1/Zfp42 is dispensable for pluripotency in mouse ES cells. BMC Dev Biol (2008) 1.43
Analysis of biological selections for high-efficiency gene targeting. Mol Cell Biol (1995) 1.20
An octamer motif contributes to the expression of the retinoic acid-regulated zinc finger gene Rex-1 (Zfp-42) in F9 teratocarcinoma cells. Mol Cell Biol (1993) 1.17
Selective disruption of genes transiently induced in differentiating mouse embryonic stem cells by using gene trap mutagenesis and site-specific recombination. Mol Cell Biol (1998) 1.15
E-MAP-115, encoding a microtubule-associated protein, is a retinoic acid-inducible gene required for spermatogenesis. Genes Dev (2000) 1.06
hnRNP C is required for postimplantation mouse development but Is dispensable for cell viability. Mol Cell Biol (2000) 1.06
Fluorescence-activated sorting of totipotent embryonic stem cells expressing developmentally regulated lacZ fusion genes. Proc Natl Acad Sci U S A (1992) 1.05
Self-deleting retrovirus vectors for gene therapy. J Virol (1996) 1.01
Genomewide trapping of genes that encode secreted and transmembrane proteins repressed by oncogenic signaling. Genome Res (2001) 0.99
Isolation and characterization of a Chinese hamster ovary mutant cell line with altered sensitivity to vaccinia virus killing. J Virol (1996) 0.95
Identification of genes induced by factor deprivation in hematopoietic cells undergoing apoptosis using gene-trap mutagenesis and site-specific recombination. Proc Natl Acad Sci U S A (1996) 0.91
Activation of cryptic 3' splice sites within introns of cellular genes following gene entrapment. Nucleic Acids Res (2004) 0.86
Mutagenesis of diploid mammalian genes by gene entrapment. Nucleic Acids Res (2006) 0.85
A replication-competent promoter-trap retrovirus. J Virol (1996) 0.80
Gene trap mutagenesis of hnRNP A2/B1: a cryptic 3' splice site in the neomycin resistance gene allows continued expression of the disrupted cellular gene. BMC Genomics (2003) 0.79
Gene trap vector screen for developmental genes in differentiating ES cells. Methods Enzymol (2003) 0.76
The trappist's approach to pathfinding: elucidating brain wiring using secretory-trap mutagenesis. Genome Biol (2001) 0.75
Modeling the study of DNA damage responses in mice. Methods Mol Biol (2015) 0.75
Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation (2001) 14.70
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell (1993) 12.02
Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature (1983) 11.61
p53 status and the efficacy of cancer therapy in vivo. Science (1994) 6.72
Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development (1993) 6.56
Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation (2001) 6.29
Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell (1993) 6.05
Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest (1999) 5.65
Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev (1993) 5.33
Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell (1996) 4.52
Analysis of human chromosome 21: correlation of physical and cytogenetic maps; gene and CpG island distributions. EMBO J (1990) 4.49
Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med (1999) 4.44
Cell adhesion events mediated by alpha 4 integrins are essential in placental and cardiac development. Development (1995) 4.44
Embryonic mesodermal defects in alpha 5 integrin-deficient mice. Development (1993) 4.22
Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins. Cell (1998) 4.20
A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci U S A (1997) 4.17
Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest (1998) 4.00
Phenotype of mice lacking functional Deleted in colorectal cancer (Dcc) gene. Nature (1997) 3.57
A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci U S A (1998) 3.54
Developmental defects in mouse embryos lacking N-cadherin. Dev Biol (1997) 3.39
Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci U S A (1999) 3.07
Two regions of the adenovirus early region 1A proteins are required for transformation. J Virol (1988) 3.02
Arthropod-borne viral infections of man in Nigeria, 1964-1970. Ann Trop Med Parasitol (1975) 2.98
Adenovirus E1A coding sequences that enable ras and pmt oncogenes to transform cultured primary cells. Mol Cell Biol (1986) 2.70
RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J Biol Chem (2000) 2.65
Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat Genet (2000) 2.53
Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat Genet (1996) 2.46
Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc Natl Acad Sci U S A (1994) 2.37
Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk--a review of the literature. Eur J Clin Nutr (2009) 2.35
Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev (2008) 2.32
H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell (1996) 2.21
Glucose-6-phosphate dehydrogenase deficient red cells: resistance to infection by malarial parasites. Science (1969) 2.21
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer. J Clin Oncol (1997) 2.17
In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes. Cell (1986) 2.13
Sequence repeats in a polyoma virus DNA region important for gene expression. J Virol (1983) 2.12
Increased sickling of parasitised erythrocytes as mechanism of resistance against malaria in the sickle-cell trait. Lancet (1970) 2.11
Precocious mammary gland development in P-cadherin-deficient mice. J Cell Biol (1997) 2.10
A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J Clin Invest (1998) 2.08
Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase. Nat Biotechnol (2001) 2.05
Differential requirements for alpha4 integrins during fetal and adult hematopoiesis. Cell (1996) 2.01
Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable. Mol Cell Biol (2000) 1.90
Immunity, transferrin, and survival in kwashiorkor. Br Med J (1970) 1.89
High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol (1995) 1.87
A foodborne outbreak of gastroenteritis associated with Norwalk-like viruses: first molecular traceback to deli sandwiches contaminated during preparation. J Infect Dis (2000) 1.81
An overview of the CERC ARTEMIS project. Proc Annu Symp Comput Appl Med Care (1995) 1.80
Dengue viruses from febrile patients in Nigeria, 1964-68. Lancet (1971) 1.79
Identification of cellular promoters by using a retrovirus promoter trap. J Virol (1989) 1.79
PUM2, a novel murine puf protein, and its consensus RNA-binding site. RNA (2001) 1.76
HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler Thromb Vasc Biol (2001) 1.74
Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc Natl Acad Sci U S A (1997) 1.66
The cellular src gene product regulates junctional cell-to-cell communication. Science (1988) 1.65
Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene. Proc Natl Acad Sci U S A (1988) 1.62
Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone. J Biol Chem (1987) 1.60
Enhanced anti-HIV functional activity associated with Gag-specific CD8 T-cell responses. J Virol (2010) 1.60
Diabetes mellitus in Nigerians: a study of 832 patients. West Afr Med J Niger Pract (1971) 1.59
A murine homolog of the yeast RNA1 gene is required for postimplantation development. Genes Dev (1994) 1.56
Multiple, targeted deficiencies in selectins reveal a predominant role for P-selectin in leukocyte recruitment. Proc Natl Acad Sci U S A (1999) 1.55
Biochemical assessment of protein-calorie malnutrition. Lancet (1969) 1.55
Mesodermal development in mouse embryos mutant for fibronectin. Dev Dyn (1996) 1.55
Localization of the sites of conduction abnormalities in a mouse model of myotonic dystrophy. J Cardiovasc Electrophysiol (1999) 1.53
A strategy for the development of secure telemedicine applications. Proc AMIA Annu Fall Symp (1997) 1.52
Alpha4 integrins regulate the proliferation/differentiation balance of multilineage hematopoietic progenitors in vivo. Immunity (1999) 1.51
The Drosophila neurogenic locus mastermind encodes a nuclear protein unusually rich in amino acid homopolymers. Genes Dev (1990) 1.51
MR of parenchymal spinal cord signal change as a sign of active advancement in clinically progressive posttraumatic syringomyelia. AJNR Am J Neuroradiol (1998) 1.51
Glucose-6-phosphate-dehydrogenase deficiency, sickling, and malaria in African children in South Western Nigeria. Lancet (1967) 1.50
Proton MR spectroscopic measurement of neurometabolites in hepatic encephalopathy during oral lactulose therapy. AJNR Am J Neuroradiol (1998) 1.50
Genetic susceptibility to ozone-induced lung hyperpermeability: role of toll-like receptor 4. Am J Respir Cell Mol Biol (2000) 1.48
Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure. AIDS Res Hum Retroviruses (2008) 1.46
Clustered illegitimate recombination events in mammalian cells involving very short sequence homologies. Nature (1983) 1.46
Fingerstick glucose determination in shock. Ann Intern Med (1991) 1.46
Functional genomics in mice by tagged sequence mutagenesis. Nat Genet (1997) 1.44
Role of P-selectin cytoplasmic domain in granular targeting in vivo and in early inflammatory responses. J Cell Biol (1998) 1.43
Crk-associated substrate p130(Cas) interacts with nephrocystin and both proteins localize to cell-cell contacts of polarized epithelial cells. Exp Cell Res (2000) 1.42
Increases in depression after cholesterol-lowering drug treatment. Behav Med (1996) 1.39
Abnormal lipoprotein metabolism and reversible female infertility in HDL receptor (SR-BI)-deficient mice. J Clin Invest (2001) 1.37
Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study. Proc Natl Acad Sci U S A (2008) 1.34
The systemic availability of oral glutathione. Eur J Clin Pharmacol (1992) 1.29
Erythromycin-sulfisoxazole vs amoxicillin in the treatment of acute otitis media in children. A double-blind, multiple-dose comparative study. Am J Dis Child (1985) 1.29
Structural and biological analysis of integrated polyoma virus DNA and its adjacent host sequences cloned from transformed rat cells. J Virol (1982) 1.27
Whole body PET/CT for initial staging of choroidal melanoma. Br J Ophthalmol (2005) 1.25
Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts. Nat Genet (2000) 1.25
Selective targeting of gene products with the megakaryocyte platelet factor 4 promoter. Proc Natl Acad Sci U S A (1991) 1.24
CTG repeats show bimodal amplification in E. coli. Cell (1998) 1.24
An enhancer element in the EphA2 (Eck) gene sufficient for rhombomere-specific expression is activated by HOXA1 and HOXB1 homeobox proteins. J Biol Chem (1998) 1.23
Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Postgrad Med J (2004) 1.22
In vivo roles of integrins during leukocyte development and traffic: insights from the analysis of mice chimeric for alpha 5, alpha v, and alpha 4 integrins. J Immunol (2000) 1.21
DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. J Clin Invest (1999) 1.20
Expression of the adenovirus E1A oncogene during cell transformation is sufficient to induce susceptibility to lysis by host inflammatory cells. Proc Natl Acad Sci U S A (1986) 1.19
Screening for acute HIV infection in South Africa: finding acute and chronic disease. HIV Med (2011) 1.19
Dystrophic muscle in mice chimeric for expression of alpha5 integrin. J Cell Biol (1998) 1.18
Pseudomonas aeruginosa bacteremia in patients with AIDS. Clin Infect Dis (1994) 1.18
Regulation of pp60c-src synthesis by inducible RNA complementary to c-src mRNA in polyomavirus-transformed rat cells. Mol Cell Biol (1986) 1.15
PDGF mediates cardiac microvascular communication. J Clin Invest (1998) 1.15
Trimethoprim-sulphamethoxazole in pertussis: comparison with tetracycline. Arch Dis Child (1972) 1.14
Relation of symptoms to impaired stomach, small bowel, and colon motility in long-standing diabetes. Dig Dis Sci (1993) 1.13
Immunoglobulins, transferrin, caeruloplasmin and heterophile antibodies in kwashiorkor. Trop Geogr Med (1970) 1.12
Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients. Eur J Cancer (2013) 1.12
Dysregulation of the adipoinsular axis -- a mechanism for the pathogenesis of hyperleptinemia and adipogenic diabetes induced by fetal programming. J Endocrinol (2001) 1.11